When the IARC, which restricts its panels to consider only a narrow spectrum of selected publications, makes a mistaken decision, the effects are harmful. Its rulings give credibility to chemophobic activists looking for headlines and raise the likelihood that substances wrongly labeled as harmful will be replaced by other products that could pose greater risks or provide fewer benefits.